Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial update on combination chemotherapy for relapsed acute myeloid leukemia; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Leukemia | Phase 2 | Status: UNKNOWN